H.C. Wainwright analyst Mitchell S. Kapoor reiterated a Neutral rating on Crescent Biopharma Inc (NASDAQ: CBIO).The analyst commented: "Consistent with ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments